Central and renal hemodynamic effects of a new agonist at peripheral dopamine- and beta-2 adrenoreceptors (dopexamine) in patients with heart failure (original ) (raw )Role of the beta2 adrenoceptor in mediating positive inotropic activity in the failing heart and its relation to the hemodynamic actions of dopexamine hydrochloride
Kenneth Borow
The American Journal of Cardiology, 1988
View PDFchevron_right
Effects of dopaminergic agents on cardiac and renal function in normal man and in patients with congestive heart failure
Kong Lie
International Journal of Cardiology, 1992
View PDFchevron_right
Haemodynamic response to dopexamine hydrochloride in postinfarction heart failure: lack of tolerance after continuous infusion
Leif Erhardt
Heart, 1988
View PDFchevron_right
Use of dopexamine hydrochloride in intensive care patients with low-output left ventricular heart failure
F. Colardyn
The American Journal of Cardiology, 1988
View PDFchevron_right
Evaluation of dopexamine hydrochloride as an anti-hypertensive agent after cardiac surgery
Gavin Kenny
International Journal of Clinical Monitoring and Computing, 1991
View PDFchevron_right
Renal hemodynamic effects of dopexamine hydrochloride
Richard Foulds
The American Journal of Cardiology, 1988
View PDFchevron_right
Human renovascular effects of dopexamine hydrochloride: A novel agonist of peripheral dopamine and beta2-adreno-receptors
Richard Foulds
European Journal of Clinical Pharmacology, 1987
View PDFchevron_right
Relative significance of dopamine receptors, beta adrenoceptors and norepinephrine uptake inhibition in the cardiovascular actions of dopexamine hydrochloride
Leonard Goldberg
The American Journal of Cardiology, 1988
View PDFchevron_right
Hemodynamic effect of dobutamine in patients with severe heart failure
Nasim Akhtar
American Journal of Cardiology, 1975
View PDFchevron_right
Effect of dopexamine hydrochloride on renal vascular resistance index and haemodynamic responses following coronary artery bypass graft surgery
Steve Bolsin
European Journal of Anaesthesiology, 1997
View PDFchevron_right
Impact of Dopamine Infusion on Renal Function in Hospitalized Heart Failure Patients: Results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial
Gregory Giamouzis , Charalambos Parisis
Journal of Cardiac Failure, 2010
View PDFchevron_right
Cardiovascular pharmacology of dopexamine in low output congestive heart failure
Philip Binkley
The American Journal of Cardiology, 1988
View PDFchevron_right
Renal effect of dopexamine hydrochloride in patients with chronic renal dysfunction
Tarek Eldiasty
Urological Research, 1992
View PDFchevron_right
Effects of dopamine on left ventricular afterload and contractile state in heart failure: Relation to the activation of beta1-adrenoceptors and dopamine receptors
Kenneth Borow
Journal of The American College of Cardiology, 1988
View PDFchevron_right
Dobutamine in chronic ischemic heart failure: Alterations in left ventricular function and coronary hemodynamics
Thomas Ports
The American Journal of Cardiology, 1981
View PDFchevron_right
Short- and long-term dobutamine treatment in chronic ischemic heart failure
Nili Zafrir
Clinical Cardiology, 1987
View PDFchevron_right
Cardiovascular effects of dobutamine in severe congestive heart failure
Joseph Andy
American Heart Journal, 1977
View PDFchevron_right
Haemodynamic response during low-dose dobutamine infusion in patients with chronic systolic heart failure: Comparison of echocardiographic and invasive measurements
Christian Tuxen
2013
View PDFchevron_right
Comparative hemodynamic effects of intravenous dobutamine and MDL-17,043, a new cardioactive drug, in severe congestive heart failure
m Iacona
American Heart Journal, 1985
View PDFchevron_right
Hemodynamic and Renal Effects of Dopexamine and Dobutamine in Patients With Reduced Cardiac Output Following Coronary Artery Bypass Grafting
Roger Royster
Chest, 1994
View PDFchevron_right
The effects of dopexamine hydrochloride on cardiopulmonary haemodynamics following cardiopulmonary bypass surgery
Yugan Mudaliar
International Journal of Cardiology, 1989
View PDFchevron_right
Low dose dopamine in prevention of GFR deterioration in acute decompensated heart failure with preserved ejection fraction
Ahmed Bendary
Journal of Cardiovascular Disease Research (JCDR), 2021
View PDFchevron_right
Selective dopamine-1 receptor agonist augments regional myocardial blood flow: comparison of fenoldopam and dopamine
Andrew Maroko
American Heart …, 1992
View PDFchevron_right
Renal synthesis of dopamine in asymptomatic post-infarction left ventricular systolic dysfunction
Patricio Soares-da-Silva
Clinical Science, 2000
View PDFchevron_right
Additive effects of dobutamine and amrinone on myocardial contractility and ventricular performance in patients with severe heart failure
Joseph Gage
Circulation, 1986
View PDFchevron_right
Dopamine-induced changes in renal blood flow in normals and in patients with renal dysfunction
Juraj Madaric
Catheterization and Cardiovascular Interventions, 2008
View PDFchevron_right
Hemodynamics and renal function during administration of low-dose dopamine in severely ill patients
José Luiz Gomes do Amaral
Sao Paulo Medical Journal, 2004
View PDFchevron_right
Effects of prolonged infusion of dopexamine on β 1 - and β 2 -adrenoceptors in guinea-pig myocardium
Roger Summers
Journal of Autonomic Pharmacology, 1990
View PDFchevron_right
The prescribing pattern of dopamine and dobutamine in congestive heart failure patients in a tertiary care teaching hospital
World Journal of Pharmaceutical Sciences
View PDFchevron_right
The hemodynamic and metabolic advantages gained by a three-day infusion of dobutamine in patients with congestive cardiomyopathy
R. Altschuld
American Heart Journal, 1983
View PDFchevron_right
Influence of dobutamine and dopamine on hemodynamics and plasma concentrations of noradrenaline and renin in patients with low cardiac output following acute myocardial infarction
Ursula Gundert-remy
European Journal of Clinical Pharmacology, 1980
View PDFchevron_right
COMPARISON OF THE VASODILATOR ACTION OF DOPAMINE AND DOPAMINE AGONISTS IN THE RENAL AND CORONARY BEDS OF THE DOG
Owen Woodman
British Journal of Pharmacology, 1982
View PDFchevron_right
Effects of dobutamine on left ventricular performance and myocardial metabolic demands in patients with ischemic heart disease
M. Vandormael
Clinical Cardiology, 1984
View PDFchevron_right
Changes in regional blood flow distribution induced by infusions of dopexamine hydrochloride or dobutamine in anesthetized dogs
George Biro
The American Journal of Cardiology, 1988
View PDFchevron_right
The renal effect of low-dose dopamine in high-risk patients undergoing coronary angiography
Morris Mosseri
Journal of the American College of Cardiology, 1999
View PDFchevron_right